TDG vs VRDN · P/E 41, rev $8.83B vs rev $425.0K
Transdigm Group Incorporated (TDG) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
TDG currently screens at market cap $73.65B and trailing P/E 41.1. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the TDG and VRDN stock pages for the full models.
Not investment advice.